Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Allergens abrogate antiinflammatory DNA effects and unmask macrophage-driven neutrophilic asthma via ILC2/STING/TNF-α signaling
Anand Sripada, Divya Verma, Rangati Varma, Kapil Sirohi, Carolyn Kwiat, Mohini Pathria, Mukesh Verma, Anita Sahu, Vamsi Guntur, Laurie Manka, Brian Vestal, Camille Moore, Richard J. Martin, Magdalena M. Gorska, John Cambier, Andrew Getahun, Rafeul Alam
Anand Sripada, Divya Verma, Rangati Varma, Kapil Sirohi, Carolyn Kwiat, Mohini Pathria, Mukesh Verma, Anita Sahu, Vamsi Guntur, Laurie Manka, Brian Vestal, Camille Moore, Richard J. Martin, Magdalena M. Gorska, John Cambier, Andrew Getahun, Rafeul Alam
View: Text | PDF
Research Article Immunology Inflammation Pulmonology

Allergens abrogate antiinflammatory DNA effects and unmask macrophage-driven neutrophilic asthma via ILC2/STING/TNF-α signaling

  • Text
  • PDF
Abstract

The mechanisms of neutrophilic and mixed neutrophilic-eosinophilic asthma are poorly understood. We found that extracellular DNA and nucleosomes (Nucs) were elevated in the airways of patients with neutrophilic-eosinophilic asthma and correlated with bronchoalveolar lavage neutrophils. Bronchial tissue from neutrophilic-eosinophilic asthma had more DNA sensor–positive cells. Intranasally administered DNA did not induce airway hyperreactivity (AHR) or any pathology but induced AHR and neutrophilic-eosinophilic inflammation when coadministered with the allergen Alternaria (Alt). Nuc alone induced antiinflammatory/defensive genes, whereas the Nuc-Alt combination increased levels of TNF-α and innate cytokines. The Alt-Nuc phenotype was abolished in Cgas–/–, ALR–/–, Sting–/–, LysMCre:Stingfl/fl, IL7RCre:Rorαfl/fl, and Tnfr2–/– mice. Alt, unexpectedly, played an essential role in the Nuc-induced phenotype. It abrogated Nuc induction of antiinflammatory genes, facilitated Nuc uptake, induced type 2 innate lymphoid cells, which, in the presence of Nuc, produced high levels of TNF-α, and promoted neutrophilic infiltration. We established a paradigm whereby allergens inhibit the antiinflammatory effects of DNA/Nuc and facilitate STING-TNF-α–driven neutrophilic-eosinophilic inflammation in asthma.

Authors

Anand Sripada, Divya Verma, Rangati Varma, Kapil Sirohi, Carolyn Kwiat, Mohini Pathria, Mukesh Verma, Anita Sahu, Vamsi Guntur, Laurie Manka, Brian Vestal, Camille Moore, Richard J. Martin, Magdalena M. Gorska, John Cambier, Andrew Getahun, Rafeul Alam

×

Figure 2

Effect of i.n. exposure to DNA, Nuc, and Alt (alone or in combination) on mouse AHR, inflammation, and mucus production.

Options: View larger image (or click on image) Download as PowerPoint
Effect of i.n. exposure to DNA, Nuc, and Alt (alone or in combination) o...
(A) A schematic of the i.n. administration of various agents and the experimental end point. (B) AHR after Sal, DNA, Alt, or Alt+DNA exposure as measured by flexiVent. εSal versus Alt+DNA, P < 0.0001; φSal versus Alt, P < 0.0001; #DNA versus Alt, P = 0.0001; δDNA versus Alt+DNA, P < 0.0001. (C–F) Differential counts of BAL macrophages, lymphocytes, eosinophils, and neutrophils (n = 5). (G and H) Morphometric quantification of peribronchial and perivascular inflammation (H&E staining of the lungs) and mucus production (PAS staining) in Sal-, DNA-, Alt-, or Alt+DNA–treated mice (n = 5). (Groups are color-coded as in B). (I) AHR after Sal, Nuc, Alt, or Alt-Nuc exposure as measured by flexiVent. RRS, respiratory system resistance. *Sal versus Nuc, P = 0.02; φSal versus Alt, P < 0.0001; εSal versus Alt-Nuc, P < 0.0001; #Nuc versus Alt, P = 0.02; δNuc versus Alt-Nuc, P < 0.0001; ψAlt versus Alt-Nuc, P = 0.006. (n = 7). (J–M) Differential counts of BAL macrophages, lymphocytes, eosinophils, and neutrophils (n = 7). (N and O) Morphometric quantification of peribronchial and perivascular inflammation and mucus production in mice treated with Sal, Nuc, Alt, or Alt-Nuc (n = 7). BM, basement membrane. (Groups are color coded as in I). (P and Q) Expression (semi-quantitative) of select cytokines and chemokines in BAL from mice treated with Sal, Nuc, Alt or Alt-Nuc, as measured by a cytokine array (n = 3). (R) AHR after Sal, DNA, or histone exposure in B6 mice (n = 5). δSal versus histone, P < 0.001; εDNA versus histone, P < 0.001. A 2-way ANOVA with Tukey’s multiple comparisons test was used to determine the statistical significance between groups. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts